feed,title,long_url,short_url
SeekingAlpha,Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xencor In $480 Million Deal,https://seekingalpha.com/article/4472166,
SeekingAlpha,Palantir Technologies: Negative Net Income Is A Result Of Positive Long-Term Investments,https://seekingalpha.com/article/4472165,
